Goldan Keith A.

Avg. Two Year Performance

(22%) Avg. Purchase Return
(11%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)(3%)(17%)(22%)(22%)
Purchase Success Rate0 of 31 of 30 of 30 of 30 of 3
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 40 of 40 of 40 of 40 of 4

Isolagen Inc.

Drugs » Drugs - Generic

SVP and CFO:

Holdings: 2.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Nupathe Inc.

Other » Other

CFO and SVP:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Syndax Pharmaceuticals Inc

Other » Other

Chief Financial Officer:

Holdings: 52.62K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Optinose, Inc.

Other » Other

Chief Financial Officer:

Holdings: 141.73K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--